We're going digital!
Kisaco Research is committed to providing attendees across all of our events with the best possible experience, it’s for this reason we’ve decided to go digital and embrace the amazing new technology that enables us to deliver a virtual event.
Why Attend
Most enzymes found in nature are not suitable for industrial purposes. The field of protein and enzyme engineering is growing at a rapid rate, with competition within industries high and the need to optimize performance greater than ever.
The virtual Protein Engineering Congress is dedicated to uncovering the new and emerging practices, techniques and methods of protein and enzyme engineering across industries.
With industry approaching the design, build, and generation of new biocatalysts and molecules not found in nature, come and learn from our line-up of leading speakers to get an update on the new technologies used in the field of strain and protein engineering.
The breadth of topics discussed at this meeting will focus in on directed evolution, computational protein design, synthetic biology and white biotechnology, and applications of enzyme and protein engineering and industrial biocatalysis in the biopharmaceutical, flavor & fragrance, cosmetics, and food industries.
Attend and you'll be able to:
- Network with key opinion leaders and acquire new customers
- Form collaborations with companies who are engineering proteins and enzymes
- Meet with new technology partners to enhance internal R&D
- Understand the new applications of engineered enzymes and learn how to scale-up to large industrial manufacture
Meet attendees from companies including:
Confirmed 2020 Speakers
Frances Arnold
Frances Arnold’s work has been recognised by many awards including the 2018 Nobel Prize in Chemistry for pioneering the use of directed evolution to engineer enzymes. Arnold is co-inventor on over 40 US patents. Throughout her esteemed career and many achievements, Frances Arnold co-founded Gevo, Inc a company to make fuels and chemicals from renewable resources in 2005. She has been on the corporate board of the genomics company Illumina Inc since 2016 and in 2019, she was named to the board of Alphabet Inc., making Arnold the third female director of the Google parent company.
At Caltech, Arnold runs a laboratory that continues to study directed evolution and its applications in environmentally friendly chemical synthesis and green/alternative energy, including the development of highly active enzymes (cellulolytic and biosynthetic enzymes) and microorganisms to convert renewable biomass to fuels and chemicals.
Andrew Buller
Hans Renata
Jared Lewis
Jeremy Steflik
Joelle Pelletier
Justin Siegel
Lori Giver
Jim Lalonde
Maria Lucas
Richard Fox
Rudi Fasan
Ryan Phelan
Stefan Lutz
Todd Hyster
Trish Choudhary
Yasuhisa Asano
John Tucker
Toby Richardson
Christina Boville
David Entwistle
Dr Christian Gruber
MAKE THE MOST OF YOUR DIGITAL EXPERIENCE
Become a Partner
Kisaco Research provides the much-needed platform on which industry executives can network, connect and learn from each other as well as meet potential industry partners.
Far from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list.
With our extensive marketing experience and strategy, your partnership with Kisaco Research will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. We value your ROI and will work with you directly on your specific goals and targets – that’s why we take special care in finding the most relevant end-users to attend, so that your financial and resource investment is smartly allocated.
Find out more by calling us at +44 (0)20 3696 2920 or email us at [email protected].
Download the Agenda
The Protein Engineering Congress USA is going virtual for 2020.
The global enzyme market is predicted to reach over $19 billion by 2025 due to cross-sector implementation of enzyme use, with the bio-pharmaceutical, agriculture, food ingredient, and flavor & fragrance industries accounting for the majority of this increase.
We are bringing together representatives from all industries to discuss how the global enzyme market is progressing and developments in the pipeline.
We are working with speakers to reconfirm their participation and will update the agenda accordingly within the next couple of weeks.
Download Agenda
Headline Sponsor
GenScript
Website: https://www.genscript.com/
GenScript Biotech is the world leader in biotechnology reagent service industry. Established in 2002 in New Jersey, United States, the company was the first to commercialize gene synthesis and successfully establish fully integrated capabilities for custom peptide synthesis, protein expression and engineering, custom antibody development and engineering, animal model development, in vitro/in vivo pharmacology as well as a variety of catalogue products, industrial enzymes and microbial reagents.
Senior Event Partner
ATUM
Website: http://www.atum.bio
ProteinGPS is an engineering technology that can modify proteins for real world applications. A small number of variants are tested using high quality assays representative of the functionality, developability and manufacturability properties that your protein will need. Iterative machine learning and testing steps result in an engineered protein that will work where it matters: the real world.
Twist Biosciences
Website: https://www.twistbioscience.com/
At Twist Bioscience, we work in service of customers who are changing the world for the better. In fields such as medicine, agriculture, industrial chemicals and data storage, by using our synthetic DNA tools, our customers are developing ways to better lives and improve the sustainability of the planet. The faster our customers succeed, the better for all of us, and Twist Bioscience is uniquely positioned to help accelerate their efforts.
Our innovative silicon-based DNA Synthesis Platform provides precision at a scale that is otherwise unavailable to our customers. Our platform technologies overcome inefficiencies and enable cost-effective, rapid, precise, high-throughput synthesis and sequencing, providing both the quality and quantity of the tools they need to rapidly realize the opportunity ahead. For more information about our products and services, please visit www.twistbioscience.com. Twist Bioscience is on Twitter. Sign up to follow our Twitter feed @TwistBioscience at https://twitter.com/TwistBioscience.
Zymvol
Website: https://zymvol.com/
Zymvol Biomodeling SL is a privately-owned company based out in Barcelona, Spain.
We are specialized in the discovery and optimization of enzymes for the biocatalytic synthesis of small molecules. We apply proprietary computational technologies that combines bioinformatics, 3D molecular modeling, and Quantum Mechanics to identify and engineering your enzymes in less than 4 weeks. We deliver samples of enzymes identified in any Enzyme Search or In Silico Design campaigns for our clients’ in-house validation. We take into account parameter like activity, selectivity, specificity, stability and solubility.
Event Partner
Biocatalysts
Website: https://www.biocatalysts.com/enzyme-development-manufacture/
Biocatalysts Inc. is a global biotechnology company producing specialty enzymes for a variety of industries, such as food, flavor & fragrance, pharmaceuticals, life sciences, fine chemicals and many more. Biocatalysts Inc. offer both off-the-shelf enzyme products and an award-winning customized enzyme discovery, development, and manufacturing service. In addition, Biocatalysts Inc. have the knowledge and experience to take a customer’s enzyme, transfer the technical process, develop & optimize fermentations and downstream processing to maximize yield and product stability, and routinely supply commercial volumes of the enzyme back to the customer.
In 2020, Biocatalysts Inc. expanded its manufacturing capabilities with the completion of an 11,000 sq ft state of the art manufacturing plant. At the core of our new plant is a 10,000L fermenter and its supporting network of seed, feed and process vessels. The new facility will increase Biocatalysts’ fermentation capacity more than fifteen-fold, establishing the company as an enzyme manufacturer on a larger commercial scale entirely, in addition to housing a suite of down-stream processing equipment improving primary recovery and enhancing spray and freeze drying, and purification capabilities.
Codexis
Website: http://www.codexis.com
Codexis, Inc. is a leading protein engineering company applying innovative technologies to unlock the power of proteins®.
Since 2002, Codexis’ scientists and bioinformatics experts have worked collaboratively with our clients to advance protein optimization and production, enabling breakthrough developments in pharmaceuticals and fine chemicals, biotherapeutics, food & beverage, agriculture and a wide range of other industries.
Guided by proprietary software and bioinformatic systems, Codexis leverages existing knowledge and expertise to improve protein stability, activity, specificity and other properties to enhance clinical function or process performance.
Our proprietary CodeEvolver® technology platform enables the rapid development and production of highly optimized proteins, custom-designed for your application. Codexis’ revolutionary approach to protein engineering starts with an understanding of the desired performance specifications and optimizes a protein specifically to fit these requirements. You get precisely the protein you need for the job you want it to do.
Denovium Inc
Website: http://www.denovium.com
Denovium is an artificial intelligence company pioneering novel AI methods to accelerate innovation in biopharma. Founded by genomics experts, we have spent decades solving complex biological problems and are passionate about creating life-changing AI solutions that will revolutionize the industry’s scientific approach.
Innophore
Website: https://innophore.com/
Innophore uses the patented 3D point cloud technology (so called Catalophores) to identify enzymes for biocatalytic industrial processes.
The search in a proprietary database of active site cavities allows customers to find new enzymes that are otherwise unpredictable.
The platform is a digital search engine for partners in the fields of pharma, chemistry, biotechnology, food, cosmetics, agriculture, textiles or diagnostics.
Artificial intelligence is applied to refine searches and get the most out of our proprietary database.
Proteus by Seqens
Website: https://proteus.seqens.com/
Please visit our website for more information.Conference Packages
Sending Your Team? Group Discounts Available!
Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates
Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off
If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920
About Kisaco Research
Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.
Meet industry peers that will help build a career-changing network for life.
Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.
Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.
Invest both in your company growth and your own personal development by signing up to one of our events and get started.